primidone (Q420383)

primidone (English)

3 October 2016

C₁₂H₁₄N₂O₂

1 reference

primidone (English)

19 November 2016

CCC1(C(=O)NCNC1=O)C2=CC=CC=C2

1 reference

https://www.whocc.no/atc_ddd_index/?code=N03AA03

primidone (English)

19 November 2016

1.25 gram

route of administration

oral administration

1 reference

reference URL

1 reference

14 February 2018

World Health Organisation international non-proprietary name

primidone (English)

1 reference

primidone (English)

medical condition treated

3 October 2016

1 reference

13 December 2016

1 reference

significant drug interaction

13 December 2016

procarbazine

hypersensitivity

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pethidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

periciazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

morphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hydromorphone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tapentadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

rac-warfarin

short coagulation time

1 reference

A reference set of clinically relevant adverse drug-drug interactions

diazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

phenobarbital

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lormetazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

nitrazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clobazam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

flurazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sodium oxybate

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alprazolam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

lorazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clonazepam

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlordiazepoxide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cognitive disorder

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

hypotension

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sedation

1 reference

A reference set of clinically relevant adverse drug-drug interactions

syncope

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tramadol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

buprenorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fentanyl

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dihydrocodeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

codeine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

alfentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

oxycodone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

procarbazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sufentanil

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pregnancy category

US pregnancy category D

1 reference

imported from Wikimedia project

1 reference

Medical Subject Headings

15 March 2018

1 reference

California Proposition 65 list of chemicals

https://oehha.ca.gov/chemicals/primidone

18 March 2020

reference URL

Commons category

Primidone

0 references

Identifiers

InChI

InChI=1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16)

1 reference

primidone (English)

19 November 2016

2 references

primidone (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

125-33-7

2 references

https://commonchemistry.cas.org/detail?cas_rn=125-33-7

primidone (English)

19 November 2016

6 April 2021

1 reference

primidone (English)

3 October 2016

2 references

primidone (English)

19 November 2016

Reaxys registry number

218034

1 reference

primidone (English)

3 October 2016

mapping relation type

2 references

PRIMIDONE (English)

19 November 2016

International Chemical Identifier

InChI

InChI=1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16)

1 reference

PRIMIDONE (English)

19 November 2016

2 references

inferred from InChIKey

MSBNK-Athens_Univ-AU151606

1 reference

MassBank accession ID

SM850201

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

MSBNK-Fac_Eng_Univ_Tokyo-JP002784

0 references

MSBNK-Keio_Univ-KO003788

0 references

MSBNK-Keio_Univ-KO003789

0 references

MSBNK-Keio_Univ-KO003790

0 references

MSBNK-Keio_Univ-KO003791

0 references

MSBNK-Keio_Univ-KO003792

0 references

0 references

0 references

0 references

0 references

MSBNK-Waters-WA000655

0 references

MSBNK-Waters-WA000656

0 references

MSBNK-Waters-WA000657

0 references

MSBNK-Waters-WA000658

0 references

SPLASH

splash10-03k9-0900000000-2791dd2c8b88ef3746e2

0 references

splash10-014i-0590000000-248d62cc8fce49dbc8ac

0 references

splash10-03xr-1910000000-defb3cb3827732984417

0 references

splash10-01ox-4900000000-2a6eec3c8ff19123ac27

0 references

splash10-0006-9800000000-6cf73d06072a870130a9

0 references

splash10-0006-9500000000-f9d1e48f1afbc27fce53

0 references

splash10-0006-9400000000-ee42f86b57749afa5326

0 references

splash10-014i-0590000000-c6e3ad2d87e33ccd0249

0 references

splash10-03xr-1910000000-4f481052510ee71cb8ae

0 references

splash10-03dl-4900000000-b796d864e3b38d92a1d4

0 references

splash10-0006-9700000000-c6a71612fcf884b362c6

0 references

splash10-0006-9400000000-2509c88567fd37a64f08

0 references

splash10-0006-9400000000-70b4eb639de5cd82206d

0 references

splash10-03k9-0900000000-32676f955580c7b188af

0 references

splash10-014i-8900000000-0e7a89b14902d3718a96

0 references

splash10-0gb9-0790000000-85b9730b3c1a612616dd

0 references

splash10-0uxr-1950000000-9a26803c7d536d7535be

0 references

splash10-1000-7940000000-13c974e8220bfde7b936

0 references

splash10-0aou-9400000000-e6ac3896e41d100eb94d

0 references

splash10-052f-9000000000-bdd6d5c0f8bd8a00b144

0 references

splash10-0006-8900000000-8251f44f80079a017e49

0 references

splash10-0006-9500000000-eca07632eb70021d3678

0 references

splash10-03k9-0900000000-104ab34d91923122fa54

0 references

splash10-03k9-0900000000-523cfc5e1d739d54e0f5

0 references

splash10-03di-2910000000-b7efd09b00e06dbafb8a

0 references

splash10-03xu-2900000000-c1f7b0b63b199254dd07

0 references

0 references

1 reference

Hazardous Substances Data Bank

28 October 2019

Primidone (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

0 references

1 reference

primidone (English)

ECHA Substance Infocard ID

19 November 2016

100.004.307

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

27 December 2018

Primidone (English)

CAS no.: 125-33-7 (English)

1 reference

Guide to Pharmacology Ligand ID

Primidone (English)

publication date

17 November 2015

5338

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

5338

D03.383.742.698.253.650.700

primidone (English)

19 November 2016

Primidone

0 references

MeSH concept ID

M0017580

0 references

MeSH tree code

0 references

RxNorm ID

8691

1 reference

primidone (English)

19 November 2016

1 reference

Human Metabolome Database ID

HMDB0014932

2 references

based on heuristic

inferred from InChIKey

2 references

primidone (English)

19 November 2016

MedlinePlus drug identifier

0 references

1 reference

primidone (English)

19 November 2016

0 references

1 reference

1 reference

primidone (English)

3 October 2016

1 reference

https://docs.openalex.org/download-snapshot/snapshot-data-format

primidone (English)

3 October 2016

0 references

1 reference

28 October 2013

Microsoft Academic ID

0 references

0 references

1 reference

26 January 2022

Römpp online ID

RD-16-04092

1 reference

imported from Wikimedia project

1 reference

primidone (English)

19 November 2016

0 references

WordNet 3.1 Synset ID

04009289-n

1 reference